N/A
Completed N=63,012
Encouraging Mail Order Pharmacy Use to Improve Outcomes and Reduce Disparities
Source: ClinicalTrials.gov NCT02621476 ↗Enrolled (actual)
63,012
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcomePrimary: Percent of Participants Using Mail Order Pharmacy (MOP) After Intervention — 10.6; 9.3 percentage of participants — p=<0.001
Summary
The investigators propose a randomized encouragement trial to encourage use of the existing mail order pharmacy services among diabetes patients with poor adherence to CVD risk factor medications in 3 health care systems: Kaiser Permanente Northern California, Harvard Pilgrim, and Kaiser Permanente Hawaii.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent of Participants Using Mail Order Pharmacy (MOP) After Intervention |
10.6; 9.3 | <0.001 sig |
Eligibility Criteria
Inclusion Criteria
- Diabetes patients who are users of CVD risk factor medications (antihypertensive therapies, antihyperlipidemics therapies, and oral antihyperglycemic therapies),
- Diabetes patients considered to be poorly adherent to CVD risk factor medications within the prior 12 months
- Diabetes patients who have not used the mail order pharmacy to fill any prescribed medications at least once in the prior 12 months
Exclusion Criteria
- Pregnancy or Dementia/Traumatic Brain Injury diagnosis in the prior 12 months
- Hospitalized, in Skilled Nursing Facility, Hospice, or Home Health at the time of randomization.
Data sourced from ClinicalTrials.gov (NCT02621476). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.